Error message

Deprecated function: Using ${var} in strings is deprecated, use {$var} instead in include_once() (line 1442 of includes/bootstrap.inc).
Deprecated function: Using ${var} in strings is deprecated, use {$var} instead in include_once() (line 1442 of includes/bootstrap.inc).
Deprecated function: Optional parameter $type declared before required parameter $nid is implicitly treated as a required parameter in include_once() (line 1442 of includes/bootstrap.inc).

T 0939/92 (Triazoles) of 12.9.1995

European Case Law Identifier:

ECLI:EP:BA:1995:T093992.19950912

Date of decision:

12 September 1995

Case number:

T 0939/92

Application number:

IPC class:

Language of proceedings:

EN

Distribution:

A

Download and more information:

Decision text in EN (PDF, 1Â MB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in:	EN
Versions:	OJ \| Published

Title of application:

Triazole herbicides

Applicant name:

AgrEvo UK Limited

Opponent name:

-

Board:

3.3.01

Headnote:

1. If a claim concerns a group of chemical compounds per se, an objection of lack of support by the description pursuant to Article 84 EPC cannot properly be raised for the sole reason that the description does not contain sufficient information in order to make it credible that an alleged technical effect (which is not, however, a part of the definition of the claimed compounds) is obtained by all the compounds claimed (see reasons 2.2.2).
2. The question as to whether or not such a technical effect is achieved by all the chemical compounds covered by such a claim may properly arise under Article 56 EPC, if this technical effect turns out to be the sole reason for the alleged inventiveness of these compounds (reasons 2.4 to 2.6).

Relevant legal provisions:

European Patent Convention 1973 Art 84
European Patent Convention 1973 Art 56

Keywords:

Clarity and support by the description (yes)
Inventive step (no)
Alleged effect not credible for all claimed alternatives
Solution to more general technical problem obvious

Catchwords:

-

Cited decisions:

T 0001/80
T 0020/81
T 0024/81
T 0022/82
T 0119/82
T 0181/82
T 0021/83
T 0219/83
T 0220/84
T 0133/85
T 0131/87
T 0157/87
T 0742/89
T 0626/90
T 0845/90
T 0409/91
T 0435/91
T 0741/91
T 0766/91
T 0439/92
T 0465/92
T 0964/92

Citing decisions:

G 0001/03
G 0002/03
G 0001/19
R 0012/12
T 0694/92
T 0169/93
T 0410/93
T 0583/93
T 0795/93
T 0515/94
T 0668/94
T 0671/94
T 0930/94
T 0077/95
T 0099/95
T 0100/95
T 0239/95
T 0311/95
T 0315/95
T 0450/95
T 0223/96
T 0367/96
T 0475/96
T 0571/96
T 0019/97
T 0438/97
T 0509/97
T 0544/97
T 0587/97
T 0641/97
T 0714/97
T 0743/97
T 0747/97
T 0821/97
T 1026/97
T 1081/97
T 0067/98
T 0083/98
T 0165/98
T 0209/98
T 0260/98
T 0351/98
T 0400/98
T 0460/98
T 0465/98
T 0534/98
T 0763/98
T 0866/98
T 0942/98
T 0973/98
T 0045/99
T 0116/99
T 0126/99
T 0682/99
T 0736/99
T 0778/99
T 1095/99
T 0101/00
T 0103/00
T 0135/00
T 0184/00
T 0268/00
T 0278/00
T 0343/00
T 0356/00
T 0745/00
T 0753/00
T 0835/00
T 0866/00
T 0877/00
T 1127/00
T 1188/00
T 0019/01
T 0236/01
T 0238/01
T 0320/01
T 0356/01
T 0916/01
T 1064/01
T 0035/02
T 0080/02
T 0182/02
T 0369/02
T 0678/02
T 0684/02
T 0850/02
T 0893/02
T 0905/02
T 0924/02
T 0971/02
T 1146/02
T 0133/03
T 0190/03
T 0262/03
T 0364/03
T 0435/03
T 0505/03
T 1057/03
T 1155/03
T 1173/03
T 1176/03
T 1232/03
T 0101/04
T 0117/04
T 0235/04
T 0252/04
T 0329/04
T 0339/04
T 0357/04
T 0435/04
T 0506/04
T 1057/04
T 1242/04
T 1329/04
T 0006/05
T 0067/05
T 0079/05
T 0092/05
T 0258/05
T 0529/05
T 0601/05
T 0602/05
T 0665/05
T 0830/05
T 1039/05
T 0005/06
T 0142/06
T 0276/06
T 0465/06
T 0578/06
T 0637/06
T 0703/06
T 0811/06
T 0884/06
T 0939/06
T 1031/06
T 1087/06
T 1114/06
T 1194/06
T 1266/06
T 1445/06
T 1707/06
T 1727/06
T 0088/07
T 0294/07
T 0305/07
T 0345/07
T 0458/07
T 0824/07
T 1050/07
T 1158/07
T 1397/07
T 1523/07
T 1544/07
T 0451/08
T 0458/08
T 0592/08
T 0620/08
T 0716/08
T 0739/08
T 0892/08
T 1069/08
T 1261/08
T 1657/08
T 1696/08
T 1851/08
T 2234/08
T 0071/09
T 0260/09
T 0589/09
T 2053/09
T 2436/09
T 0447/10
T 0509/10
T 0592/10
T 1012/10
T 1689/10
T 1915/10
T 1925/10
T 2068/10
T 2077/10
T 2134/10
T 2418/10
T 0359/11
T 0401/11
T 0415/11
T 0516/11
T 0568/11
T 0625/11
T 0790/11
T 0862/11
T 1089/11
T 1212/11
T 0388/12
T 0519/12
T 1119/12
T 1862/12
T 2001/12
T 0261/13
T 0574/13
T 0664/13
T 0867/13
T 1311/13
T 2020/13
T 2329/13
T 0215/14
T 0420/14
T 0489/14
T 0975/14
T 1175/14
T 1433/14
T 1845/14
T 0533/15
T 0756/15
T 0827/15
T 0832/15
T 0910/15
T 1484/15
T 1984/15
T 2284/15
T 0189/16
T 0488/16
T 0875/16
T 0946/16
T 1044/16
T 1294/16
T 1469/16
T 2320/16
T 2530/16
T 0044/17
T 0206/17
T 0853/17
T 0902/17
T 1020/17
T 1169/17
T 1207/17
T 1625/17
T 1649/17
T 1715/17
T 2724/17
T 0115/18
T 0311/18
T 0321/18
T 2798/18
T 0028/20
T 2015/20

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t920939ex1.html

Date retrieved: 17 May 2021

141 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPO Guidelines - D Opposition and Limitation/Revocation Procedures

X GL D V 4 Insufficient disclosure of the invention

EPO Guidelines - G Patentability

X GL G VII 2 State of the art; date of filing

X GL G VII 10.1 Predictable disadvantage; non-functional modification; arbitrary choice

X GL G VII 12 Selection inventions

Offical Journal of the EPO

X OJ EPO SE 1/2021, p179 - Annex 1 - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2020)

X OJ EPO SE 1/2020, p174 - Annex 1 - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2019)

X OJ EPO SE 1/2019, p158 - XVI. - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2018)

X OJ EPO 2019, A86 - Interlocutory decision of Technical Board of Appeal 3.5.07 dated 22 February 2019 - T 489/14

X OJ EPO SE 6/2017, p46 - C. Inventive step

X OJ EPO SE 2/2015, p11 - I. PATENTABILITY

Case Law Book: I Patentability

X CLR I C 2.8.1 Definition of "common general knowledge"

X CLR I C 2.8.5 Proof of common general knowledge

X CLR I D 1 Introduction

X CLR I D 2 Problem and solution approach

X CLR I D 4.3 Formulation of the technical problem

X CLR I D 4.6 Solving a technical problem – post-published documents

X CLR I D 5 "Could-would approach"

X CLR I D 8.3 Skilled person – level of knowledge

X CLR I D 9.8.3 Broad claims

X CLR I D 9.19.1 Foreseeable disadvantageous or technically non-functional modifications

X CLR I D 9.19.8 Choice of one of several obvious solutions

X CLR I D 10.9 Comparative tests

Case Law Book: II Conditions to be met by an Application

X CLR II A 3.1 Introduction and general principles

X CLR II A 5.1 General principles

X CLR II A 5.2 Restrictions on generalising the technical information and examples adduced in the description

X CLR II C 3.2 Alleged effect not a feature of the claims

X CLR II C 6.1 Repeatability

Case Law Book: III Amendments

X CLR III G 4.3.1 General – "Balance of probabilities"

Case Law Book: IV Divisional Applications

X CLR IV B 4.1.3.A Notoriously well-known technical features

Case Law of the Enlarged Board

X G 0001/03 (Disclaimer/PPG) of 8.4.2004

X G 0002/03 (Disclaimer/GENETIC SYSTEMS) of 8.4.2004

General Case Law

X R 0012/12 (Antrag auf ÃberprÃ¼fung/DEUTSCHE SISI-WERKE) of 14.1.2013

X T 0001/80 (Carbonless copying paper) of 6.4.1981

X T 0020/81 (Aryloxybenzaldehydes) of 10.2.1982

X T 0024/81 (Metal refining) of 13.10.1982

X T 0022/82 (Bis-epoxy ethers) of 22.6.1982

X T 0119/82 (Gelation) of 12.12.1983

X T 0181/82 (Spiro compounds) of 28.2.1984

X T 0219/83 (Zeolites) of 26.11.1985

X T 0133/85 (Amendments) of 25.8.1987

X T 0626/90 (Production of peptides/TERUMO) of 2.12.1993

X T 0409/91 (Fuel oils) of 18.3.1993

X T 0435/91 (Detergents) of 9.3.1994

X T 0741/91 (BON-3-acid/Ueno) of 22.9.1993

X T 0766/91 (Decorative laminates/BOEING) of 29.9.1993

X T 0439/92 (Trennwand/ALTURA) of 16.5.1994

X T 0465/92 (Aluminium alloys) of 14.10.1994

X T 0694/92 (Modifying plant cells) of 8.5.1996

X T 0964/92 (Benzodioxane derivatives/EISAI) of 23.8.1994

X T 0169/93 (Dandricidal compositions/JOHNSON & JOHNSON) of 10.7.1996

X T 0410/93 () of 16.7.1996

X T 0583/93 () of 4.1.1996

X T 0795/93 (Versteifungsmaterial/GIULINI) of 29.10.1996

X T 0515/94 (Converted Starches/NATIONAL STARCH) of 29.10.1997

X T 0668/94 (Fungicides/ZENECA) of 20.10.1998

X T 0671/94 (Lidded paint container/ICI) of 11.6.1996

X T 0930/94 (Papier/ROQUETTE FRERES) of 15.10.1997

X T 0311/95 (Production of carbon black/WITCO) of 16.6.1999

X T 0223/96 (Protein C/ELI LILLY) of 29.1.1999

X T 0367/96 (Request of correction/L'AIR LIQUIDE) of 21.6.2001

X T 0019/97 (Abtrennen von Alkoholen/COGNIS) of 31.7.2001

X T 0438/97 () of 9.2.1999

X T 0641/97 (Chinacridonpigmente/CLARIANT) of 17.10.2000

X T 0714/97 () of 27.6.2000

X T 0743/97 (Thrombolytic proteins/GENETICS INSTITUTE) of 26.7.2000

X T 0747/97 () of 1.2.2000

X T 0067/98 (Friction modifier/EXXON) of 9.10.2001

X T 0209/98 (Phenylcyclohexane/MERCK) of 26.6.2001

X T 0260/98 () of 23.1.2003

X T 0351/98 (HIV-I/CHIRON CORPORATION) of 15.1.2002

X T 0400/98 (LAYERED CATALYST/CHEVRON) of 19.9.2002

X T 0534/98 (Ausreichende Substantiierung des Einspruchs) of 1.7.1999

X T 0942/98 (Phenylurazile/BASF) of 13.2.2001

X T 0736/99 () of 20.6.2002

X T 0103/00 (Imidazolium salts/UNIVERSITY OF ALABAMA) of 1.4.2003

X T 0268/00 (Purification/SYNGENTA) of 16.12.2003

X T 0278/00 (Naphthyl compounds/ELI LILLY) of 11.2.2003

X T 0835/00 () of 7.11.2002

X T 0866/00 (DÃ©rivÃ©s du titane/ATOFINA) of 30.9.2003

X T 1127/00 (Ribozymes/GENE SHEARS) of 16.12.2003

X T 1188/00 () of 30.4.2003

X T 0320/01 (Pyridones/AVENTIS) of 12.3.2004

X T 1064/01 (Sulfamic acids/SEARLE, MONSANTO) of 25.3.2004

X T 0369/02 () of 7.7.2005

X T 0684/02 () of 12.10.2007

X T 0850/02 () of 5.4.2005

X T 0893/02 (GP75/SLOAN-KETTERING) of 26.5.2004

X T 0924/02 (Fluorierte Alkane/BAUSCH & LOMB) of 4.11.2004

X T 0190/03 (Partiality/XXX) of 18.3.2005

X T 1173/03 (Collections/SPIROGEN) of 29.6.2006

X T 0235/04 (Composition for dyeing of human hair/KAO) of 29.6.2006

X T 0329/04 (Absorption of minerals/NESTLE) of 4.8.2005

X T 1057/04 (Composition de teinture d'oxydation contenant une laccase / L' … of 14.3.2007

X T 1242/04 (Provision of product-specific data/MAN) of 20.10.2006

X T 1329/04 (Factor-9/JOHN HOPKINS) of 28.6.2005

X T 0006/05 (Method for transferring heat/SOLVAY SOLEXIS) of 9.10.2007

X T 0258/05 () of 21.6.2007

X T 0601/05 (Anti-TNF alpha human monoclonal antibodies/BAYER III) of 2.12.2009

X T 0005/06 (Folate complex/PURDUE RESEARCH FOUNDATION) of 23.1.2009

X T 0142/06 () of 11.3.2008

X T 0276/06 (Intravascular stents/MEDTRONIC) of 25.9.2008

X T 0578/06 (Pancreatic cells/IPSEN) of 29.6.2011

X T 0637/06 (Cosmetic compositions/PROCTER & GAMBLE) of 26.6.2007

X T 0811/06 () of 11.5.2010

X T 0884/06 (Phytate compositions/AVEVE) of 7.11.2007

X T 1194/06 (Arylalkylamine carbamates/LABOARATORIOS S.A.L.V.A.T.) of 6.8.2009

X T 0305/07 (Trisulfides/PFIZER) of 20.5.2011

X T 0458/07 (Ion exchange chromatography method/GENENTECH) of 23.9.2009

X T 0824/07 () of 5.10.2007

X T 1397/07 (Dimerisation process/NESTLE OIL OYJ) of 6.5.2010

X T 1523/07 (Washing a device for the production of meth(acrylic)acid or esters/ … of 24.11.2009

X T 1544/07 (Stabilised peroxidicarbonate/ARKEMA) of 19.8.2010

X T 0620/08 (Oxo-pyridine/ENCYSIVE) of 4.5.2011

X T 0716/08 (Infectious salmon anaemia virus vaccine/INTERVET) of 19.8.2010

X T 0739/08 (Destillative Trennung von AMCPA aus HMD/BASF) of 9.6.2011

X T 0892/08 (Detergent granules/PROCTER) of 15.9.2010

X T 1069/08 (Desaturase/CALGENE) of 8.9.2011

X T 0071/09 (Composition de teinture/L'OREAL) of 3.7.2012

X T 0447/10 (Composition de teinture / L'OREAL) of 14.11.2013

X T 1925/10 () of 17.12.2014

X T 2068/10 (Fixed-dried platelets/UNIVERSITY NORTH CAROLINA) of 21.5.2012

X T 2134/10 (S. pneumoniae antigen/HUMAN GENOME SCIENCES) of 14.11.2013

X T 2418/10 (Production of glycolaldehyde/RESOURCE TRANSFORMS INT.) of 3.11.2011

X T 0359/11 () of 13.5.2015

X T 0415/11 (Lyophilized Neisseria meningococcus vaccine/NOVARTIS) of 12.1.2012

X T 0568/11 () of 20.11.2015

X T 0625/11 () of 19.1.2017

X T 0862/11 (Polyelektrolytkapselsystem /HENKEL) of 17.3.2015

X T 1089/11 (Serum-free medium/BAVARIAN NORDIC) of 12.12.2017

X T 0388/12 () of 7.3.2017

X T 0519/12 () of 17.3.2017

X T 1862/12 (Inspecting Articles / KIMBERLEY-CLERK) of 9.10.2018

X T 2001/12 () of 29.1.2015

X T 0867/13 (Pompe disease/DUKE UNIVERSITY) of 6.3.2018

X T 1311/13 (LPS binding peptides/ NATIONAL UNIVERSITY OF SINGAPORE) of 17.1.2018

X T 2020/13 () of 12.10.2017

X T 0420/14 () of 31.5.2017

X T 0489/14 (Pedestrian simulation/CONNOR) of 22.2.2019

X T 1175/14 () of 8.8.2017

X T 1845/14 () of 8.11.2018

X T 0488/16 (Dasatinib/BRISTOL-MYERS SQUIB) of 1.2.2017